文献速递乳房整形与再造美容整形

乳房假体分枝杆菌感染:流行病学综述与结局分析

Breast Implant Mycobacterial Infections: An Epidemiologic Review and Outcome Analysis.
PubMed 文献 · Plast Reconstr Surg · 2018-01-01

文献计量分析显示本世纪以来发展中国家假体周围分枝杆菌感染增多,平均年龄37.9岁,多数为双侧隆乳,平均潜伏期9个月,最常见为乳房疼痛或压痛,偶发分枝杆菌占52.6%。即刻取出伴或不伴延迟再植入是最常用手术策略,辅以平均4.6个月联合抗菌治疗,平均随访39.7个月,复发率12.3%。

要点

  • 美容医疗旅游相关假体周围分枝杆菌感染增多,需告知公众风险。
  • 多数患者表现为乳房疼痛或压痛,平均潜伏期9个月。
  • 偶发分枝杆菌最常见(52.6%),即刻取出联合抗菌治疗为主要策略。

核心结论

  • 美容医疗旅游相关的假体周围分枝杆菌感染出现,提示临床医生需教育公众相关风险。
  • 本研究识别了与假体周围分枝杆菌感染复发相关的危险因素。

研究设计与样本

  • 检索Biosis、Embase、LILACS、MEDLINE和Web of Science数据库自建库至2017年12月,检索词为「Breast Implants」和「Mycobacterial Infections」及等同词。

主要发现

  • 文献计量病例分析显示本世纪以来发展中国家假体周围分枝杆菌感染增多。
  • 患者平均年龄37.9岁,多数接受双侧乳房隆乳术。
  • 多数患者表现为乳房疼痛或压痛,平均潜伏期9个月。
  • 偶发分枝杆菌(Mycobacterium fortuitum)从90例中分离出(52.6%)。
  • 平均随访39.7个月,171例中21例(12.3%)观察到复发。

关键数值与推荐

  • 即刻取出伴或不伴延迟再植入是最常用手术策略,辅以平均4.6个月联合抗菌治疗。

临床怎么用

  • 对假体周围分枝杆菌感染,可考虑即刻取出假体伴或不伴延迟再植入,并联合平均4.6个月抗菌治疗。
  • 需关注美容医疗旅游相关的感染风险,并对公众进行风险教育。

局限性

  • 流行病学证据有限,本文为综述性汇总分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Epidemiologic evidence of periprosthetic mycobacterial infections is limited. The recent boom in cosmetic surgery tourism has been associated with a rise of surgical-site infections in returning patients. This review aims to explore available data, examine trends of documented periprosthetic mycobacterial infections, and analyze outcomes of management techniques. METHODS: A search in the Biosis, Embase, LILACS, MEDLINE, and Web of Science databases from inception until December of 2017 for "Breast Implants" and "Mycobacterial Infections" and equivalents was performed. Data were pooled after two screening rounds following full-text retrieval and cross-referencing. RESULTS: Forty-one reports describing 171 female patients who had breast prosthesis-related mycobacterial infections were identified. Bibliometric case-based analysis revealed a rise of periprosthetic mycobacterial infections in developing countries since the start of the millennium. The mean patient's age was 37.9 years and the majority of patients had undergone bilateral breast augmentation. Most patients presented with breast pain or tenderness, after an average incubation period of 9 months. Mycobacterium fortuitum was isolated from 90 cases (52.6 percent). Immediate explantation with or without delayed reimplantation was the most commonly used surgical strategy, complemented by combination antimicrobial therapy for an average of 4.6 months. The mean follow-up time was 39.7 months, during which recurrence was observed in 21 of 171 patients (12.3 percent). CONCLUSIONS: The emergence of periprosthetic mycobacterial infections in relation to cosmetic medical tourism alerts clinicians to the importance of educating the public about the associated risks. In addition, this study identifies risk factors associated with recurrence of periprosthetic mycobacterial infections.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Al-Halabi B, Viezel-Mathieu A, Shulman Z, et al. Breast Implant Mycobacterial Infections: An Epidemiologic Review and Outcome Analysis. Plast Reconstr Surg. 2018. PMID: 30096121. doi:10.1097/PRS.0000000000004892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。